Actofit, a digital health startup is poised for a significant leap forward with a $10M investment from Mirai Capital announced as part of its Series A round at a prominent healthcare event in UAE. This strategic financial infusion underscores Actofit's mission to strengthen its grip in the Middle East markets.
Mirai Capital, a forward-thinking global investment management firm, recognizes the growing personalised digital health market size and the increasing healthcare spending across preventive care. This partnership is poised to redefine the future of health management through innovative solutions.
Actofit, a dedicated player in addressing chronic health issues, offers a wide range of devices measuring over 150 parameters enabling earlier detection of chronic diseases and proven DTx programs to remission such conditions. With a user base exceeding 1 million, Actofit empowers individuals to make sustainable lifestyle changes, promoting overall well-being and remission of chronic diseases.
With Mirai Capital's substantial support, Actofit is ready to play a key role in this transformation.
